NCT06891001

The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity

Not yet recruiting NA Last updated 22 January 2026

What this trial tests

NA trial testing Unilateral neutral shoe insert in Gluteus Medius Muscle Strength in 36 participants. Not yet recruiting.

Timeline

1 January 2027

Primary endpoint
1 January 2028

1 January 2029

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	1 January 2027
Primary completion	1 January 2028
Estimated completion	1 January 2029
Sites	1 location across United States

Drugs / interventions tested

• Unilateral neutral shoe insert
• Bilateral Shoe Insert
• Physical Therapy

Conditions studied

• Gluteus Medius Muscle Strength — all drugs for Gluteus Medius Muscle Strength →
• Lateral Hip Pain — all drugs for Lateral Hip Pain →
• Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy — all drugs for Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy →

Sponsor

Mayo Clinic

Who can join

Adults 18 to 70, any sex, with Gluteus Medius Muscle Strength or Lateral Hip Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compared to physical therapy with sham inserts (PT+Sham) and physical therapy (PT) alone. In addition, we hypothesize that the addition of a neutral shoe insert in the involved limb will immediately improve biomechanics and pain with the single-leg stance test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.